BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 29390103)

  • 1. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
    Targher G; Mantovani A; Pichiri I; Mingolla L; Cavalieri V; Mantovani W; Pancheri S; Trombetta M; Zoppini G; Chonchol M; Byrne CD; Bonora E
    Diabetes Care; 2014 Jun; 37(6):1729-36. PubMed ID: 24696459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
    PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
    Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
    BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between fatty liver disease and chronic kidney disease.
    Chen PC; Kao WY; Cheng YL; Wang YJ; Hou MC; Wu JC; Su CW
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):42-50. PubMed ID: 30876789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
    Roderburg C; Krieg S; Krieg A; Demir M; Luedde T; Kostev K; Loosen SH
    Eur J Med Res; 2023 Apr; 28(1):153. PubMed ID: 37062837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease.
    Hydes T; Buchanan R; Kennedy OJ; Fraser S; Parkes J; Roderick P
    BMJ Open; 2020 Sep; 10(9):e040970. PubMed ID: 32988952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
    Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
    J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
    Önnerhag K; Dreja K; Nilsson PM; Lindgren S
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):542-550. PubMed ID: 30827925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
    Papademetriou M; Athyros VG; Geladari E; Doumas M; Tsioufis C; Papademetriou V
    Curr Vasc Pharmacol; 2018; 16(3):254-268. PubMed ID: 28676027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease.
    Kaps L; Labenz C; Galle PR; Weinmann-Menke J; Kostev K; Schattenberg JM
    United European Gastroenterol J; 2020 Oct; 8(8):942-948. PubMed ID: 32698692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up.
    Zeng J; Sun C; Sun WL; Chen GY; Pan Q; Yan SY; Xu ZJ; Chen YW; Fan JG
    J Dig Dis; 2017 Apr; 18(4):229-236. PubMed ID: 28296249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients.
    Lascasas JMSS; Fonseca I; Malheiro J; Santos S; Campos A; Castro A; Moreira C; Correia S; Beirão I; Lobato L; Cabrita A
    J Bras Nefrol; 2019; 41(1):29-37. PubMed ID: 31063177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
    Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.